Genescience Pharmaceuticals Co., Ltd.

GeneScience Pharmaceuticals Co., Ltd. (GenSci) is the leading biopharmaceutical company in China focused on developing, manufacturing and marketing protein therapeutic products and biological supergenerics with special emphasis on endocrinology and related areas, aiming at providing affordable and innovative biopharmaceutical products to patients.

GenSci is headquartered in Changchun, China, with 6 approved products on the market, including Jintropin™ somatropin (rhGH for injection), Jintropin™ AQ somatropin liquid pen, Scimax™ filgrastim (rhG-CSF injection), Granmac™ molgramostim (rhGM-CSF for injection), Jintrotide™ (octreotide acetate for injection) and Jintrirelin™ (triptorelin acetate injection).

GenSci's core product, GenLei® Jintropin™ (rhGH, somatropin for injection) has been the leading brand of rhGH in China with a dominant 70% of the market share. GenSci's profitability has been ranked No. 1 among Chinese biopharmaceutical companies.